Lloyd Balbuena

2 papers in the library · 12 citations · publishing 2018-2025

Papers

Sort Most recent Most cited

Efficacy and safety of esketamine versus propofol in electroconvulsive therapy for treatment-resistant depression: A randomized, double-blind, controlled, non-inferiority trial.

Journal of Affective Disorders 2025 Qing-Bin Zeng, De-Cheng Zou, Xing-Bing Huang et al. 12 citations

Electroconvulsive therapy (ECT) is a commonly used alternative for treatment-resistant depression (TRD). Although esketamine has a rapid pharmacological antidepressant action, it has not been studied as an ECT anesthetic. The objective of this study was to compare the efficacy and safety of esketamine with propofol when both are used as ECT anesthetic agents. Forty patients with TRD were...

DOI: 10.1016/j.jad.2024.09.038 Full text Esketamine Propofol Electroconvulsive therapy ect Shock therapy +7

Ketamine-based anesthesia improves electroconvulsive therapy outcomes: a randomized-controlled study.

Canadian journal of anaesthesia = Journal canadien d'anesthesie June 2018 Jonathan J Gamble, Henry Bi, Rudy Bowen et al.

Major depressive disorder (MDD) is a common and debilitating condition that can be challenging to treat. Electroconvulsive therapy (ECT) is currently the therapeutic gold standard for treatment-resistant MDD. We tested our hypothesis that ketamine-based anesthesia for ECT results in superior improvement in treatment-resistant MDD outcomes compared with propofol-based anesthesia. Patients with...

DOI: 10.1007/s12630-018-1088-0 Full text